{"name":"Skyhawk Therapeutics, Inc.","slug":"skyhawk-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxQRk90RUNCOXNlREczcjZLQ09tSXk0VGxNSXpzRU5OUFhERC1fVWF1eXM3VEI3Z0wyLS1FclVEX1hKTnFSMWN3c2NPRnRDZUlLWkdYb2ZENkpWQzhEUnpra3JpNFBlay1xMVpVZWozSjJObEU3ZE0tUHZZMFV3RTl1eG5RSmFCcUpjcmJQT3RGM2xkUFkxVk0taVpDQXR1Zi03WGt0T01sT2UxUXRVZDM3Y0xzbDhrT2gwajhzY2c1VHdMTTk1UzdKaVVjUEpyczNSQS05OFJwUUF4WFh4QTFmNGx6d0xpZ1FnSVF4SDhLRnM1ZW9TSTJjUkVoTnY5WU9xQmVsUE4wT0Rva1FMdDkydENBdGRnQQ?oc=5","date":"2026-03-10","type":"pipeline","source":"prnewswire.com","summary":"Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntington's Disease - prnewswire.com","headline":"Skyhawk Therapeutics Appoints Aaron Deves as Chief Commercial Officer to Lead Commercialization of SKY-0515 for Huntingt","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxPYlBmMW9iRnFINlpMVmVKME1OLVdDYjhCVE5jZ1RpdlhILVliYTNXeGFpOWxTck16cHhuZkl2T25UQjVVdWFRX21Cdl9TbjY3S1lNV2NIdlhyME5WRF95OWNXZEZQcERYOGJ5VW10bW1lU0tLdmNzbFZyMktDRTY3a29ib2IyMUtUNVUzeW1TdXRyU0VtUnM3MGJIU1Bmc2tjMEJ5dElFcGozLWQ2aFVURzBaZlhCODhtR09QWFVHNlM1MXpfbTUwRjJhWUdEdWhXdWI1dVVYeUJ5YVdoNDhKYjVxYlQ4dGstT1M5MF9qNlQyaWhVbENQbVV1N1AtendUTUJUdXVSQTRrRVpRcWZoeFR2WjFvWFUxbGdFUzhycE9uZGs2NHg2ZUhwTEMwU0ozeVVNSE5JMA?oc=5","date":"2025-09-17","type":"trial","source":"prnewswire.com","summary":"Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease - prnewswire.com","headline":"Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQV3VKcFhiQ0hYcllMRDBGZlU1MllWMUhMd1czN0hQMnF0TlZ5dzI2bFREdGxzWXQxYVVHMUZLOTdIc2Voc0dKQ25RRlFqRm5tRU5iLTRCMVZmWGx0d1IxdDdFWUdEMks1NGNLMG5SNjlXMlNaUFZaVkNIMm91UU92M0R2akloWHdVQ1h4THdrUEdRN2xCQVMzR0RDYkR2eExXVnJXRDI0V19wYmpNXzJkTlczQzdrLVNsaGV3dzc0NmhYMEVJRENNRF84ZXdlYnU4U2tOcFo5NzJSM0REeXFxRjVkNU5INXlwUDRQNk9qbkYxU0lsdVJnOHBZU0ZlSGQzcGw5SXdkNHd6clp3NkxSTWE1dl9FUmVEdFlHVWhUc3FzSU1XSGg0RDVjbkhQeUppdFNDamtfdHY2d0hSTHM1eg?oc=5","date":"2025-08-18","type":"deal","source":"prnewswire.com","summary":"Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeting Small Molecules for Neurological Disorders - prnewswire.com","headline":"Skyhawk Therapeutics Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany to Discover Novel RNA-Targeti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQVlNBNzZsUjlPUzEtcy14UGx4NjR3NTBrTE1zY0NndnliSWVwa1VidTE1VHFIYW90ZkRza2Fza3RpUnBZVEROdVd3UmRUNlhFNHNFNHlKRWlkS1o4eElnWVBBTU1DT3otNVVFRlBuMGFYcVgwdG54TzgzdjlDWFdraC1qTVRrRDRxeEZOb0dSQXlicjZ6bG1XWGN5T3VjTGp2OUZqUno2YVU?oc=5","date":"2025-08-18","type":"deal","source":"The Business Journals","summary":"Waltham biotech’s latest pharma deal valued at $2B - The Business Journals","headline":"Waltham biotech’s latest pharma deal valued at $2B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNc214UGV3NXdueVVsS1A4TnN6MFhVZzd3aDlncWtOYmM0UXlEUERvMmpFU0ZMYnVBcmVCX0dQZUxibHlBbTUtMDIxME92Q0NIVHVyT3lIXzF0clcxVWZPVGRReV9qWmJ3NS1FN3VWUERkU0RrNUlQOGVoUjFRT0dlVi1VWkJYTWtTeGE1Nl8wRzN5dTNSSHY3VzNIVVlYTDAwc3c?oc=5","date":"2025-08-18","type":"pipeline","source":"BioSpace","summary":"Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech - BioSpace","headline":"Merck KGaA Drops up to $2B in Skyhawk Collab for RNA-Targeting Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxOa0M0bVJ2d1RaNmtUVm5xLUdmM3FCUF9DRVNnLU10QjBWU3ZiZTRzQmVOckZtdEhrZFF1dmg0M2lMUzJLaUtFcUE1MnRkQTdhbWo0ZklMUlZHYjZCbHRQSkJiVG1wMU02SmYyX0VSQndqaU1Wd2VmSVUtSjVCUUdiVGR1M2kxVzhRN3JHMFBydElDRmxNd09kbWNOTHN6QW1VdjBmWmpKci0yNXFOVy1PVXlxTlljYl9yVXR5UGVRWl8wRXlUYmVLeTdOX0tadno2NGdaVnE0ZTEzdjRDTDVKU2pvZXZGZDVCTGJMd3pId0pMYjg3NUp3cG80c1l1V1E?oc=5","date":"2025-06-17","type":"trial","source":"prnewswire.com","summary":"Skyhawk Therapeutics Announces First Patient Dosed in Phase 2/3 FALCON-HD Trial of SKY-0515 for Huntington's Disease - prnewswire.com","headline":"Skyhawk Therapeutics Announces First Patient Dosed in Phase 2/3 FALCON-HD Trial of SKY-0515 for Huntington's Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOQTgtWVFHbm9ndmZPbTlUV0Ftc0E1bS1seV8xdnk5NW1YN3VjM29rS1ZuejB5R2hjaW5YQWp2eFJwOS1PSHRnYkVXVFl5NXpDTFgybXpmZ3Zlb1Y0MG91WU1DcV9UQlpQOW9fbVJweWxfZXlrd21EY2I3aUtZUFpEa0RGTl9mYU1WY3J3SjZnY1BjTmx2RkxONE1vUm1Ec3lIbnZsSXFNR0c2d2dPOG4zRlE0YklQVWJobGFhRDl3QW03Nk9OakJ0WXNVSXNUSVA2elJrdWRrajc0bFhy?oc=5","date":"2024-06-11","type":"pipeline","source":"citybiz","summary":"Skyhawk Therapeutics Promotes Clint Musil to CEO and Appoints Co-founder Bill Haney to Executive Chairman - citybiz","headline":"Skyhawk Therapeutics Promotes Clint Musil to CEO and Appoints Co-founder Bill Haney to Executive Chairman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPYm9iSzd5dFlXX1QtaHRzVWF3S08wR0k5OWQyRy1qbzc5Sm5rX2F5NDhPX1ExRS16a2pYdWJ1S19RV0YtTDZzM1gxY0wxX2c1aWFKVGVDWUluV2ctREVJOHo2N3JJSDBtc2Q3MkZJQ3dkODg1a2VkZnQxQ0V5am1TUW4wZ3d5V2d0UG1IWlNodUVzLTVJbWtDX2lLTDQyakRvMEg1WHhKNzRxR0ZHcXF6M2RBNV9TWjRuSFBIVy1WNXQyd20wUkZiVTBCSHFmRmhtZDZYQVNuMThFR3M?oc=5","date":"2024-04-22","type":"deal","source":"Ipsen","summary":"Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases - Ipsen","headline":"Ipsen and Skyhawk Therapeutics announce RNA targeting research collaboration in rare neurological diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQeHZ5SU9DRFlqM2lWR1RmU3o1VHA2cmh6dFJjSzNwamF1dHhWTE5hUThib2pWZ2xhUE02MlB6YzUwQ0ZzMTFqVXBmU1MzU190WU9Oa1k5QkRqMFh2WnpDWVdNRlpLWUFfM3Fwbi05SXNtYWZlbXk0UW56R0drZ1RaVzV6QjQ5Znd2YUlWNWRmZw?oc=5","date":"2024-04-22","type":"pipeline","source":"BioPharma Dive","summary":"Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases - BioPharma Dive","headline":"Ipsen, Skyhawk to develop RNA-targeting pills for rare brain diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQUkNacmNndTZfWDNTdEM4b0Nid3lna3pBOGlaYWtvM2ZjNG5ZMXFacGlvbWtMQjNRb1lMeEFpdGljSUpCU2hkR295dzlSb24wY3VzVDlob21fTzFDSS1FbzlMV0JRWnIzRTA1X1FvUU53a0Q4bGpHc0FCWmVrblBqM1BPeG5hR21B?oc=5","date":"2024-04-22","type":"deal","source":"The Business Journals","summary":"Skyhawk’s latest biopharma collaboration is worth up to $1.8B - The Business Journals","headline":"Skyhawk’s latest biopharma collaboration is worth up to $1.8B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOOFV3OE9TN3E1ODRxbVdVaGNJWU9DQWt3VC1VcWNWcERpaHRYMnNMMDJON1VPblFONTFqdE1CMnY0ekFWbEl0WmJxZ01OVWhQNWZjY1dKN3ZubGJjVm44dXM2SDVIUU5iWUNzS3NRckJJb0NNY3ZnZHdyaGVxWU02SGV2c2hiQUlIU2JCUDYzMGZKNUU2Q1BHYUQ3OHhCVENpMTV2MA?oc=5","date":"2021-09-15","type":"pipeline","source":"The Business Journals","summary":"RNA startup raises $133M in 'last investment before a public offering' - The Business Journals","headline":"RNA startup raises $133M in 'last investment before a public offering'","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNRXdDcFRMRjNQd2xFMlhocHhlczQtb0FhUENyZmcyMTVnUkFxalJtUTNlWXZ4ZkpMQlV1Y2JHT2hwRHp2dS1CN0VxSGxNR0ZmZXFaYVNfSmpjZkx0N0tMTXdpQU9PSmZvLURYdlpKRWhfS2FqemtvNnpHN0U5V2xfZXV4TzdDakc2aXcxalh3UQ?oc=5","date":"2018-06-26","type":"deal","source":"Pharmaceutical Technology","summary":"Skyhawk’s STAR collaboration with Celgene - Pharmaceutical Technology","headline":"Skyhawk’s STAR collaboration with Celgene","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}